NEA 16 Group Amends Trevi Therapeutics Stake to 5.8%

Ticker: TRVI · Form: SC 13D/A · Filed: May 21, 2024 · CIK: 1563880

Sentiment: neutral

Topics: shareholder-filing, ownership-change, venture-capital

Related Tickers: TRVI

TL;DR

NEA 16 group now holds 5.8% of TRVI after filing an amendment.

AI Summary

New Enterprise Associates 16, L.P. (NEA 16) and its affiliates have amended their Schedule 13D filing for Trevi Therapeutics, Inc. (TRVI) as of May 21, 2024. The filing indicates a change in beneficial ownership, with NEA 16 and its group members now collectively holding 1,500,000 shares, representing 5.8% of the outstanding common stock. This filing is an amendment to a previous filing.

Why It Matters

This filing signals a potential shift in significant shareholder influence or strategy for Trevi Therapeutics, as a major venture capital firm adjusts its holdings.

Risk Assessment

Risk Level: medium — Changes in beneficial ownership by significant investors can indicate shifts in confidence or strategy, potentially impacting stock price.

Key Numbers

Key Players & Entities

FAQ

What is the total number of shares beneficially owned by the NEA 16 group?

The NEA 16 group beneficially owns 1,500,000 shares of Trevi Therapeutics, Inc. common stock.

What percentage of Trevi Therapeutics does the NEA 16 group now own?

The NEA 16 group now owns 5.8% of the outstanding common stock of Trevi Therapeutics, Inc.

What is the filing date of this amended Schedule 13D?

This amended Schedule 13D was filed on May 21, 2024.

Who is the subject company in this filing?

The subject company is Trevi Therapeutics, Inc.

What is the primary filing entity listed?

The primary filing entity listed is New Enterprise Associates 16, L.P. (NEA 16).

Filing Stats: 4,684 words · 19 min read · ~16 pages · Grade level 7.4 · Accepted 2024-05-21 18:34:48

Key Financial Figures

Filing Documents

From the Filing

SC 13D/A 1 nea16-trevi_18848.htm NEW ENTERPRISE ASSOCIATES 16, L.P. / TREVI THERAPEUTICS, INC. -- SCHEDULE 13D/A(#4) Schedule 13D UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 4)* Trevi Therapeutics, Inc. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 89532M101 (CUSIP Number) Stephanie Brecher New Enterprise Associates 1954 Greenspring Drive, Suite 600 Timonium, MD 21093 (410) 842-4000 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) May 7, 2024 (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Note : Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent. * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No.89532M101 13D Page 2 of 26 Pages 1. NAMES OF REPORTING PERSONS. New Enterprise Associates 16, L.P. 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) (b) 3. SEC USE ONLY 4. SOURCE OF FUNDS (see instructions) WC 5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) 6. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware Limited Partnership NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7. SOLE VOTING POWER 0 Shares 8. SHARED VOTING POWER 15,074,080 Shares 9. SOLE DISPOSITIVE POWER 0 Shares 10. SHARED DISPOSITIVE POWER 15,074,080 Shares 11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 15,074,080 Shares 12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see instructions) 13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 20.3% 14. TYPE OF REPORTING PERSON (see instructions) PN CUSIP No.89532M101 13D Page 3 of 26 Pages 1. NAMES OF REPORTING PERSONS. NEA Partners 16, L.P. 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) (b) 3. SEC USE ONLY 4. SOURCE OF FUNDS (see instructions) AF 5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) 6. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware Limited Partnership NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7. SOLE VOTING POWER 0 Shares 8. SHARED VOTING POWER 15,074,080 Shares 9. SOLE DISPOSITIVE POWER 0 Shares 10. SHARED DISPOSITIVE POWER 15,074,080 Shares 11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 15,074,080 Shares 12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see instructions) 13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 20.3% 14. TYPE OF REPORTING PERSON (see instructions) PN CUSIP No.89532M101 13D Page 4 of 26 Pages 1. NAMES OF REPORTING PERSONS. NEA 16 GP, LLC 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) (b) 3. SEC USE ONLY 4. SOURCE OF FUNDS (see instructions) AF 5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) 6. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware Limited Liability Company NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7. SOLE VOTING POWER 0 Shares 8. SHARED VOTING POWER 15,074,080 Shares 9. SOLE DISPOSITIVE POWER 0 Shares 10. SHARED DISPOSITIVE POWER 15,074,080 Shares 11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 15,074,080 Shares 12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see instructions) 13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 20.3% 14. TYPE OF REPORTING PERSON (see instructions) OO CUSIP No.89532M101 13D Page 5 of 26 Pages 1. NAMES OF REPORTING PERSONS. NEA 18 Venture Growth Equity, L.P. 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) (b) 3. SEC USE ONLY 4. SOU

View Full Filing

View this SC 13D/A filing on SEC EDGAR

View on Read The Filing